about
Calorie restriction induces mitochondrial biogenesis and bioenergetic efficiencyAnimal models of frailty: current applications in clinical research.A systematic review of the emerging definition of 'deprescribing' with network analysis: implications for future research and clinical practiceReview of epidemiology and management of atrial fibrillation in developing countriesHyperlipidemia and surfactants: the liver sieve is a linkImpact of high risk drug use on hospitalization and mortality in older people with and without Alzheimer's disease: a national population cohort studyImpact of Longevity Interventions on a Validated Mouse Clinical Frailty Index'Real-world' haemorrhagic rates for warfarin and dabigatran using population-level data in New Zealand.Estimation of lean body weight in older community-dwelling menAnalgesic use, pain and daytime sedation in people with and without dementia in aged care facilities: a cross-sectional, multisite, epidemiological study protocol.Medication safety in residential aged-care facilities: a perspective.Drug-induced liver injury in older adults.Central nervous system medication use and incident mobility limitation in community elders: the Health, Aging, and Body Composition study.Drug Burden Index in older adults: theoretical and practical issues.Methodological challenges in determining longitudinal associations between anticholinergic drug use and incident cognitive decline.High risk prescribing in older adults: prevalence, clinical and economic implications and potential for intervention at the population levelClinical pharmacology of analgesic medicines in older people: impact of frailty and cognitive impairmentPolypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes.Age-related pseudocapillarization of the liver sinusoidal endothelium impairs the hepatic clearance of acetaminophen in rats.Effects of old age on vascular complexity and dispersion of the hepatic sinusoidal networkA cluster-randomized controlled trial of a computerized antithrombotic risk assessment tool to optimize stroke prevention in general practice: a study protocol.Caloric restriction reduces age-related pseudocapillarization of the hepatic sinusoid.The hepatic sinusoid in aging and cirrhosis: effects on hepatic substrate disposition and drug clearance.Physical functioning measures and risk of falling in older people living in residential aged care facilities.The association between benzodiazepine use and sleep quality in residential aged care facilities: a cross-sectional studyCaloric restriction versus drug therapy to delay the onset of aging diseases and extend life.Contemporary approaches to managing atrial fibrillation: A survey of Australian general practitioners.Statin use and clinical outcomes in older men: a prospective population-based study.Clinical pharmacology in the geriatric patient.N-Acetyl cysteine does not prevent liver toxicity from chronic low-dose plus subacute high-dose paracetamol exposure in young or old miceEducation and Assessment of Pharmacists on the Use of the Drug Burden Index in Older Adults Using a Continuing Professional Development Education MethodFactors associated with antidepressant use in residents with and without dementia in Australian aged care facilitiesDietary approaches that delay age-related diseases.Ultrastructure of the liver microcirculation influences hepatic and systemic insulin activity and provides a mechanism for age-related insulin resistanceOptimizing Stroke Prevention in Patients With Atrial Fibrillation: A Cluster-Randomized Controlled Trial of a Computerized Antithrombotic Risk Assessment Tool in Australian General Practice, 2012-2013.Number and dosage of central nervous system medications on recurrent falls in community elders: the Health, Aging and Body Composition studyAdverse Geriatric Outcomes Secondary to Polypharmacy in a Mouse Model: The Influence of AgingDrug Burden Index and physical function in older Australian men.Effect of central nervous system medication use on decline in cognition in community-dwelling older adults: findings from the Health, Aging And Body Composition Study.Variability in response to medicines in older people: phenotypic and genotypic factors.
P50
Q24541443-7A3DAE04-4F22-4CE7-B5B1-66EF4B72D2BCQ28066389-FC7C3966-B118-4BFC-A0ED-6B1CE2CBC820Q28078344-A9E1C67C-73C9-4B93-98EB-F8AA666A645BQ28111783-C9D4414C-60C1-47E6-943B-A6C2F3DE612DQ28295565-C81C15C8-EF20-4D2A-A6F9-D856530B1C9EQ28538635-3DBD02FC-7A6A-4EB8-BF12-4A285AC2C340Q30362276-E2230B12-02BB-4221-ABD1-6F11A48B7143Q31027024-892EA54C-41F8-4C54-8B6C-560E414C1CE5Q33668185-D54E440E-2EEA-4974-8CBD-034095FBE741Q33795585-B847454A-A438-4E79-88B0-486F773C3B64Q33949205-05B8B49F-04F5-4E2D-8CE1-CF0E224FF319Q33949227-6CF53557-110F-4BB6-9928-D798739E871DQ33998004-A8591150-AC77-4F6C-B405-A1F9440A8488Q34198674-53898C46-099F-491B-A3F8-7856A11F8D47Q34521956-B70C0E8B-79A6-49AC-875D-178263A18F9BQ34578984-F2231702-F042-48FD-B92A-98EFDE3D4DD6Q34608990-82A896BE-579C-4149-A27B-B0DB8134C817Q34639755-2B4266C4-6E24-41EF-B395-971788855F0FQ34660298-3CBB9C88-F305-47C3-80FC-49ECAFC493A6Q34849634-894D68FA-84C3-48EC-A2EE-E848DBC33C74Q35089113-41B49365-A0B1-4BED-8494-C815711F3411Q35842581-9AAAF01B-E841-4986-8630-9B62F1C94161Q36012870-817357A9-C643-4F73-8515-226339DBBBF8Q36059584-E582FF9A-766B-446F-BA88-5D984A53FF0FQ36204523-F826654A-47EE-458F-B709-E19E8D32874CQ36272897-3D7F9943-75C2-48B5-B47F-F9B45F39CE0DQ36360590-17450B52-11E0-4143-8AAE-B664605D2C65Q36730168-6092E0F8-3282-4463-816C-07CDBB55EEEBQ36830192-588B12C7-D61D-4485-9687-A8A4E009DA63Q36892811-71531BC1-587E-4900-96B1-DC44A95309A5Q36965534-E89253B3-DD42-4048-BB89-7A6DEAF1C36CQ36967188-97E283B1-6094-4E5D-BDF5-0A1C532A87CDQ37019058-4144E37C-2282-42D8-B2E7-E87879504608Q37066958-EADA3AA7-1278-43FD-80F6-22A6214D1CA5Q37109120-6BEA3830-3235-45D5-B175-4E86436C0CDDQ37132135-7F5CF1DF-B9AE-4E1D-B5C9-DBA0232B8A31Q37224015-E6E2A318-8A8C-4818-9B14-BA7CE611D990Q37321432-1E07B086-F7EA-4E09-982F-7065EF3ACA2BQ37347897-4D22B983-2B7D-4B30-A357-05062E680534Q37395760-E0AEDBE4-7249-49B3-9D1C-F54CBD330869
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Sarah N. Hilmer
@ast
Sarah N. Hilmer
@en
Sarah N. Hilmer
@es
Sarah N. Hilmer
@sl
type
label
Sarah N. Hilmer
@ast
Sarah N. Hilmer
@en
Sarah N. Hilmer
@es
Sarah N. Hilmer
@sl
prefLabel
Sarah N. Hilmer
@ast
Sarah N. Hilmer
@en
Sarah N. Hilmer
@es
Sarah N. Hilmer
@sl
P106
P1153
6507153340
P21
P31
P496
0000-0002-5970-1501